Eckert & Ziegler Strahlen- und Medizintechnik AG

M&A Activity • Sep 14, 2007

News Details

Corporate | 14 September 2007 11:49

Eckert & Ziegler acquires cyclotron in the Rhineland

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Acquisition

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 14 September 2007 – Eckert & Ziegler AG (ISIN DE0005659700), a
specialist for isotope technology applications in medicine and industry,
has acquired the radiopharmaceutical manufacturer MC Pharma GmbH. Effective
today, the 16 employees and the cyclotron for producing radioactive
contrast agents are now part of the Pankow-based Eckert & Ziegler Group,
which is continuing to expand its position as a manufacturer of
radiopharmaceutical products for new nuclear medical imaging processes.

The contrast agents or 'tracers' made in cyclotrons are used in PET scans
(Positron Emission Tomography). This new imaging process can diagnose
cancer and other diseases very accurately and safely, and is playing an
increasingly important role in precisely assessing cancer and monitoring
its treatment. Already well established in many European countries, PET
scans were just included in the catalogue of treatments remunerated by
German state health insurance companies this summer. One of their major
uses is in diagnosing lung cancer.

Eckert & Ziegler is one of the largest producers of PET tracers in Central
Europe and operates its own cyclotrons, including in Berlin and Milan. In
1998, MC Pharma built one of the first private-sector cyclotrons in
Germany, and has since become a leading supplier of PET tracers in the
Rhineland area.

The Executive Board

Your contact:
Eckert & Ziegler AG
Thomas Scheuch, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin
phone: +49 (0) 30 / 94 10 84-139; fax: -112; e-mail:
thomas.scheuch@ezag.de, www.ezag.de

14.09.2007 Financial News transmitted by DGAP

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Geregelter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---